search Created with Sketch.
search Created with Sketch.

Advertisement

Breast Implants: Assessing the Risk for BIA-ALCL
Breast Implants: Assessing the Risk for BIA-ALCL

Breast Implants: Assessing the Risk for BIA-ALCL

Following new warnings from the FDA, Allergan has pulled its textured breast implants from the market. Bryan G. Forley, MD reviews what is known about the reported cases of BIA-ALCL and explains what patients and surgeons should be vigilant for. The cancer is rare, he notes, and so far only associated with textured implants—which were not commonly used in the US.

Advertisement